GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
PE-22-28 10mg

PE-22-28 10mg

PE-22-28

CAS: N/A

$89.99$99.9910% OFFIn Stock

PE-22-28 is a BDNF loop IV mimetic peptide designed to activate TrkB receptors. Studied for rapid antidepressant-like effects and neuroprotection. Modeled on the neurotrophin interface that engages TrkB without full BDNF size or stability limitations. 99.0% HPLC purity.

Specifications

Vial Size10mg
FormLyophilized Powder
Purity99.0% HPLC
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Selective TrkB partial agonism mimicking BDNF loop IV interaction. Activates downstream MAPK/ERK and PI3K/Akt neuroprotective pathways while avoiding the tropomyosin kinase-associated pleiotropic effects of full BDNF.

Research FAQ

How does PE-22-28 relate to BDNF?

PE-22-28 is a short peptide mimicking the loop IV region of BDNF that binds TrkB. It produces TrkB-mediated neuroprotection without the pharmacological challenges of the full 27kDa BDNF protein (poor stability, CNS penetration, pan-Trk activity).

Related Compounds